Skip to main content
. 2021 Aug 12;12:20406223211033119. doi: 10.1177/20406223211033119

Figure 3.

Figure 3.

Correlation between MRI-PDFF and CAP. (a) All patients at baseline. (b) All patients at the 6th month. (c) Steatosis changes measured by MRI-PDFF and CAP in all patients. (d) Patients with biopsy at baseline. (e) Patients with biopsy at the 6th month. (f) Steatosis changes measured by MRI-PDFF and CAP in patients with biopsy. (g) Patients without biopsy at baseline. (h) Patients without biopsy at the 6th month. (i) Steatosis changes measured by MRI-PDFF and CAP in patients without biopsy.

CAP, controlled attenuation parameter; MRI-PDFF, magnetic resonance imaging-estimated proton density fat fraction.